Jalal Zakaria, Malekzadeh-Milani Sophie, Hofbeck Michael, Al Najashi Khalid, Thambo Jean-Benoit, Boudjemline Younes
Department of Congenital and Pediatric Cardiology, Centre de Référence Malformations Cardiaques Congénitales Complexes-M3C, Necker Hospital for Sick Children, Assistance Publique des Hôpitaux de Paris, Pediatric Cardiology, Paris, France; Department of Congenital Adult Cardiology, Centre de Référence Malformations Cardiaques Congénitales Complexes-M3C, George Pompidou European Hospital, Assistance Publique des Hôpitaux de Paris, Unit for Adults with Congenital Heart Defects, Paris, France; Department of Pediatric and Adult Congenital Heart defects, University Hospital of Bordeaux, Pessac, France.
Catheter Cardiovasc Interv. 2015 Mar;85(4):604-10. doi: 10.1002/ccd.25747. Epub 2014 Dec 5.
This article sought to describe a new modification of the Melody valve that allows percutaneous pulmonary valve implantation (PPVI) in complex outflow tracts.
PPVI has been validated as a valuable therapeutic option for the management of patients with dysfunctional right ventricular outflow tracts (RVOT). However, complex and unfavourable RVOT anatomy continue to limit the indications for PPVI.
Between April 2012 and November 2013, PPVI was performed in 10 patients (mean age = 16, 3 ± 5 years old) using a new modification of the Melody® valve consisting in a manual shortening of the Melody by folding the two extremities of the stent. We reviewed the results of this technique.
Indications were short RVOT in three patients, prevention of retrosternal compression in two patients, bioprosthetic valves in four and coronary arteries proximity in one. No complication occurred during procedures. All patients had excellent hemodynamic results [mean post PPVI RV-PA gradient was 14 ± 6 mm Hg, three patients had trivial pulmonary regurgitation (PR) and the remaining had no PR]. After a mean follow-up of 11 months (range 5-21 months), no patient had reintervention. No valve dysfunction or stent fractures were observed.
The "Folded valve technique" is a safe modification of the Melody valve. By shortening the valve, this technique allowed PPVI in short and complex RVOTs with vulnerable neighborhood.
本文旨在描述一种对美敦力旋律瓣膜的新改良方法,该方法可用于在复杂流出道中进行经皮肺动脉瓣膜植入术(PPVI)。
PPVI已被确认为治疗右心室流出道(RVOT)功能障碍患者的一种有价值的治疗选择。然而,复杂且不利的RVOT解剖结构仍然限制了PPVI的适应症。
在2012年4月至2013年11月期间,对10例患者(平均年龄16.3±5岁)使用一种新改良的美敦力旋律瓣膜进行PPVI,该改良方法是通过折叠支架的两端手动缩短美敦力旋律瓣膜。我们回顾了该技术的结果。
适应症包括3例RVOT短的患者,2例预防胸骨后压迫的患者,4例生物人工瓣膜患者和1例冠状动脉靠近的患者。手术过程中未发生并发症。所有患者的血流动力学结果均极佳[PPVI术后平均右心室-肺动脉压差为14±6 mmHg,3例患者有轻微肺动脉反流(PR),其余患者无PR]。平均随访11个月(范围5 - 21个月)后,无患者需要再次干预。未观察到瓣膜功能障碍或支架断裂。
“折叠瓣膜技术”是对美敦力旋律瓣膜的一种安全改良。通过缩短瓣膜,该技术可在短而复杂且周围结构脆弱的RVOT中进行PPVI。